T5	Subject 0 11	The patient
T7	Effect 22 40	occipital infarcts
T8	Treatment 63 95	extremely elevated levels of PPA
T10	Drug 92 95	PPA
T6	Adverse_event 12 21	developed
E1	Adverse_event:T6 
A1	Severity E1 High